A Cost Effectiveness Analysis of Obinutuzumab In The Management of Chronic Lymphocytic Leukemia In Greece
Abstract
Authors
H Kousoulakou T Krivasi X Caporis F Theodoropoulou M Geitona
H Kousoulakou T Krivasi X Caporis F Theodoropoulou M Geitona
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now